Written by Dr Cathy Tralau-Stewart, the European Pharmaceutical Manufacturer article describes the evolution of target validation in drug discovery, ways of tackling project attrition, and the role of human organoid models in future drug discovery strategies.

Read the full article on European Pharmaceutical Manufacturer here.

An experienced therapeutics development scientist and pharmacologist, Cathy has worked within some of the world’s leading pharma and academic research establishments, developing a broad knowledge of drug discovery and the translation of early research innovation into developable drug discovery programmes.